T WAVE ALTERNATION: CAN UNPREDICTABLE EVENTS BE PREDICTED?
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The current concepts regarding the microvolt Twave alternation, methods of its quantitative evaluation are considered; the data of clinical studies, which have been performed using the given technique in patients with both the depressed and intact left ventricular ejection fraction at the background of both ischemic and non ischemic cardiomyopathies, as well as in the acute period of myocardial infarction, the Brugada syndrome, and wide QRS complexes were given.
About the Authors
T. V. Treshkur
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Росмедтехнологий», Санкт-Петербург
Russian Federation
Russian Federation
A. A. Tatarinova
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Росмедтехнологий», Санкт-Петербург
Russian Federation
Russian Federation
E. V. Parmon
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Росмедтехнологий», Санкт-Петербург
Russian Federation
Russian Federation
References
1. Myerburg R.J. Sudden Cardiac Death: Exploring the Limits of Our Knowledge // J Cardiovasc Electrophysiol. 2001.-V.12. -P. 369-381.
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure // N Engl J Med.-2005.-V.352.-P.225-237.
3. Armoundas A.A., Cohen R.J. Clinical utility of T-wave alternans // Card Electrophysiol Rev.- 1997.-V.1.-P.390-394.
4. Bloomfield D.M., Cohen R.J. Repolarisation alternans. London: BMJ Books.- 2001.-P. 256-265.
5. Rosenbaum D.S., Albrecht P., Cohen R.J. Predicting sudden cardiac death from T-wave alternans of the surface electrocardiogram: promise and pitfalls // J Cardiovasc Electrophysiol.-1996.-V. 7.P.1095-1111.
6. Smith J., Clancy E., Valeri C., et al. Electrical alternans and cardiac electrical instability // Circulation. -1988.-V.77.-P.110-121.
7. Nearing B.D., Huang A.H., Verrier R.L. Dynamic tracking of cardiac vulnerability by complex demodulation of the T-wave // Science.-1991.-V.252.-P.437-440.
8. Adam D.R., Powell A., Gordon H., Cohen R.J. Ventricular fibrillation and fluctuations in the magnitude of the repolarization vector // IEEE Comput Cardiol. -1982.-P.241-244.
9. U.S. Food and Drug Administration (FDA). Center for Devices and Radiological Health (CDRH). Available at URL address: http: // www.fda.gov/cdrh/pdf5/k050225. pdf.
10. Rosenbaum D.S., Jackson L.E., Smith J.M., et al. Electrical alternans and vulnerability to ventricular arrhythmias // N Engl J Med.-1994.-V.330.-P.235-241.
11. Nearing B. D., Verrier R. L. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy // J. Appl. Physiol.-2002.-V. 92.-P.541-549.
12. Narayan S.M. T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias // J Am Coll Cardiol. 2006.-V.47. -P.269-281.
13. Bloomfield D.M., Hohnloser S.H., Cohen R.J. Interpretation and classification of microvolt T-wave alternans tests // J Cardiovasc Electrophysiol. -2002.-V.13.-P.502-512.
14. Verrier R.L., Nearing B.D., La Rovere M.T., et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic events // J Cardiovasc Electrophysiol. -2003.-V.14.-P. 705-711.
15. Gehi A.K., Stein R.H., Metz L.D., Gomes J.A. Microvolt T-wave alternans for risk stratification of ventricular tachyarrhythmic eventsa meta-analysis // J Am Coll Cardiol.-2005.-V.46.-P.75-82.
16. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease Multicenter Unsustained Tachycardia Trial (MUSTT) // N Engl J Med.-1999.-V.341.-P. 1882-1890.
17. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction // N Engl J Med.- 2002.-V.346.-P. 877-883.
18. Center for Medicare and Medicaid Services. Medicare Announces Its Intention to Expand Coverage of Implantable Cardioverter Defibrillators, 2005. Available at: http: // www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148.
19. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction // N Engl J Med.- 2004.-V.351.-P.2481-2488.
20. Reynolds M.R., Josephson M.E. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debaterisk stratification, costs, and public policy // Circulation. 2003.-V. 108.-P.1779-1783.
21. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapya solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum // Circulation. 2004.-V.110.-P.1885-1889.
22. Chow T. MASTER I: Disappointment for T-Wave Alternans Testing. American Heart Association 2007, Scientific Sessions, November 7, 2007 (Orlando, FL). Available at URL address http: // www.theheart.org/article/825631. do.
23. Chow T., Kereiakes D.J., Bartone C. et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy // J Am Coll Cardiol.-2006.- V.47.-P. 1820-1827.
24. Chow T., Kereiakes D.J., Bartone C., et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy // J Am Coll Cardiol. -2007.-V.49(1).-P.50-58.
25. Hohnloser S.H., Ikeda T., Bloomfield D.M., et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation // Lancet. -2003.-V.362.-P.125-126.
26. Klingenheben T., Zabel M., D’Agostino Sr R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure // Lancet.-2000.-V.356.-P.651-652.
27. Ikeda T., Saito H., Tanno K., et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction // Am J Cardiol. -2002.-V.89.-P.79-82.
28. Armoundas A.A., Hohnloser S.H., Ikeda T., Cohen R.J. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation? // Nat Clin Pract Cardiovasc Med.- 2005.- V.10.-P.522-528.
29. Buxton A.E., Lee K.L., Hafley G.E., et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial // Circulation.- 2002.-V.106.-P.2466-2472.
30. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification // J Am Coll Cardiol.-2000.-V.36.-P.2247-2253.
31. Tanno K., Ryu S., Watanabe N., et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias. A prospective study using atrial pacing // Circulation.- 2004.-V.109.-P. 1854-1858.
32. Narayan S.M., Smith J.M., Schechtman K.B., et al. T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival // Heart Rhythm.-2005.-V.2.-P.234-241.
33. Costantini O., Rosenbaum D. Progress in Clinical Trials // Clin. Cardiol.-2007. -V.30-P. 97-100.
34. Ikeda T., Yoshino H., Sugi K., Tanno K., et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study // J Am Coll Cardiol.-2006.V.48(11).-P.2268-74.
35. Tapanainen J.M., Still A-M., Airaksinen K.E.J., Huikuri H.V. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarctionresults of a prospective follow-up study // J Cardiovasc Electrophysiol.-2001.-V.12.-P. 645-652.
36. Schwab J., Weber S., Schmitt H., et al. Incidence of T wave alternation after acute myocardial infarction and correlation with other prognostic parametersresults of a prospective study // Pacing Clin Electrophysiol.-2001.-V.24.-P.957-961.
37. Hohnloser S.H., Kuikuri H., Schwartz P.J., et al. T-wave alternans in post myocardial infarction patients (ACES Pilot Study) // J Am Coll Cardiol.- 1999.V.33(Suppl A).-P.144.
38. Hohnloser S.H., Klingenheben T., Bloomfield D., et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathyresults from a prospective observational study // J Am Coll Cardiol.-2003.-V.41.-P.2220-2224.
39. AHA/ACC Foundation/Heart Rhythm Society. Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death // Circulation.- 2008.-V.118.-P.1497-1518.
40. Zipes D.P. et al. ACC/AHA/ESC PRACTICE GUIDELINES ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death // JACC. -2006.-V.48(5).-P.e247-e346.
41. Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998 // Circulation.-2001.-V. 104.-P.2158-2163.
42. Ganz L.I., Traub D.M.VT, VF and SCD: the present and the future // Heart Rhythm 2008.
43. Exner D.V., Kavanagh K.M., Slawnych M.P., et al. Noninvasive Risk Assessment Early After a Myocardial Infarction. The REFINE Study // J Am Coll Cardiol. -2007.-V.50.-P.2275-2284.
44. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia // N Engl J Med.- 1996.-V.335.-P.1933.
45. Prystowsky E.N. Screening and therapy for patients with nonsustained ventricular tachycardia // Am J Cardiol.- 2000.V.86.-P.K34-39.
46. Woo M.A. Use of heart rate variability in specific populations // Futura Publishing.-199. -P.163-185.
47. Farrell T.G., Bashir Y., Cripps T., et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram // J Am Coll Cardiol.-1991.V.-18.-P.687-697.
48. Kitamura H., Ohnishi Y., Okajima K., et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy // J Am Coll Cardiol.-2002.-V.39.-P.295-300.
49. Grimm W., Christ M., Bach J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy. Results of the Marburg Cardiomyopathy Study // Circulation.-2003.-V. 108.-P.2883-2891.
50. Salerno-Uriarte J.A., et al. Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy. Results of the ALPHA Study // J Am Coll Cardiol.-2007.-V. 50.-P.1896-1904.
51. Klingenheben T. Microvolt T-Wave Alternans for Arrhythmia Risk Stratification in Left Ventricular Dysfunction // J Am Coll Cardiol.-2007.-V.50.-P.174-175.
52. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction // J Am Coll Cardiol.-2006.V.47.P.456-463.
53. Klingenheben T., Ptaszynski P., Hohnloser S.H. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure // J Cardiovasc Electro-physiol.-2005.- V.16(6)P.620-624.
54. Momiyama Y., Hartikainen J., Nagayoshi H., et al. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy // Jpn Circ J.-1997.-V.61.-P.650-656.
55. Kon-No Y., Watanabe J., Koseki Y., et al. Microvolt T-wave alternans in human hypertrophyelectrical instability and abnormal myocardial arrangement // J Cardiovasc Electrophysiol.-2001.-V.12.-P. 759-763.
56. Kuroda N., Ohnishi Y., Yoshida A., et al. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy // Circ J.-2002.-V.66(5).-P.457-462.
57. Zimetbaum P.J., Buxton A.E., Batsford W., et al. Electrocardiographic predictors of arrhythmic death and total mortality in the Multicenter Unsustained Tachycardia Trial // Circulation.- 2004.-V.110.-P.766-769.
58. Rashba E.J., Osman A.F., MacMurdy K., et al. Influence of QRS duration on the prognostic value of T wave al. ternans // J Cardiovasc Electrophysiol.- 2002.-V. 13.-P.770-775.
59. Cruz Filho F., Maia I., Fagundes M., et al. Electrical behavior of T-wave polarity alternans in patients with congenital long QT syndrome // J Am Coll Cardiol.-2000.-V.;36.-P.167.
60. Chinushi M., Restivo M., Caref E.B., El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long QT syndrometridimensional analysis of the kinetics of cardiac repolarization // Circ Res.-1998.-V.83.-P.614-628.
61. Nemec J., Ackerman M.J., Tester D.J., et al. Catecholamine-provoked microvoltage T wave alternans in genotyped long QT syndrome Pacing // Clin Electrophysiol.- 2003.-V.26.-P.1660-1667.
62. Morita H., Morita S., Nagase S., et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome // J Am Coll Cardiol.-2003.-V.42.-P. 1624-1631.
63. Ikeda T., Sakurada H., Sakabe K., et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndromeinsight into risk stratification // J Am Coll Cardiol.- 2001.-V.37.-P.1628-1634.
64. Ikeda T., Takami M., Sugi K., et al. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest // Ann Noninvasive Electrocardiol.-2005.- V.10(4).-P.396-403.
65. Kop W.J., Krantz D.S., Nearing B.D., et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls // Circulation.-2004.-V.109.-P.1864-1869.
66. Narayan S.M., Lindsay B.D., Smith J.M. Demonstrating the pro-arrhythmic preconditioning of single premature extrastimuli using the magnitude, phase and temporal distribution of repolarization alternans // Circulation.-1999.-V.100.-P. 1887-1893.
67. Gehi A.K., Stein R.H., Metz L.D., Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis // J Am Coll Cardiol.-2005.- V.46.-P.75-82.
Review
For citations:
Treshkur T.V., Tatarinova A.A., Parmon E.V. T WAVE ALTERNATION: CAN UNPREDICTABLE EVENTS BE PREDICTED? Journal of Arrhythmology. 2009;(58):42-51. (In Russ.)
Views:
130
ISSN 1561-8641 (Print)
ISSN 2658-7327 (Online)
ISSN 2658-7327 (Online)
Email this article 